ENDOMETRIY GIPERPLAZIYALARINI PATOMORFOLOGIK JIHATLARI (adabiyot sharhi)
Keywords:
Endometriy, giperplaziya, patogenez, morfologiya.Abstract
Endometriyal giperplaziya - bu polietiologik patologik jarayon bo'lib, uning patogenezi tizimli jarayonlar (neyroendokrin, metabolik va immun) va mahalliy o'zgarishlarning (endometriy hujayralarining retseptorlari va genetik apparati holati) murakkab o'zaro ta'siridan iborat. Biologik faol moddalarning ishtiroki, o'sish omillari, proliferatsiya va apoptoz belgilari va boshqalar tasvirlangan. Endometriyning turli tarkibiy qismlarining funktsional holati butun hayz davrida heterojenlik bilan tavsiflanadi.
Endometriydagi giperplastik jarayonlar keng tarqalgan ginekologik patologiya bo'lib, ularning chastotasi premenopauzada yoshga bog'liq gormonal o'zgarishlar davrida sezilarli darajada oshadi.
References
Гиперпластических процессов эндометрия. //Акушерство і гінекологія. Міжнародний медичний журнал, 2017, № 4. C 47-52.
Кумар В. И др. Основы патологии заболеваний по Роббинсу и Котрану / пер. с англ.; под ред. Е.А. Коган, и др. В 3 т. Том 3: - М.: Логосфера, 2016. 1167-1168С.
Леваков С.А. Лечение пациенток с эндометриальной гиперплазией / С.А Леваков, Н.А. Шешукова, О.В. Большакова // Проблемы репродукции. – 2017. – № 2. – С. 33–36.
Фон Вульфф М., Штуте П. Гинекологическая эндокринология и репродуктивная медицина / Пер. с нем., под ред. Е.Н. Андреевой. – М.: МЕДпресс-информ, 2017. – С. 127–129; 378–380.
Чернуха Г.Е., Асатурова А.В., Иванов И.А., Думановская М.Р. Структура патологии эндометрия в различные возрастные периоды. Акушерство и гинекология. 2018; 8: 129–34
Ahmed R.H. Ahmed, Eman M.S. Muhammad. E-cadherin and CD 10 expression in atypical hyperplastic and malignant endometrial lesions // J Egypt Nation Can Inst. — 2014. — Vol. 26. — № 4. — P. 211–217
Chandra V., Kim J.J., Benbrook D.M., Dwivedi A., Rai R. Therapeutic options for management of endometrial hyperplasia. J. Gynecol. Oncol. 2016; 27(1): e8. doi: 10.3802/jgo.2016.27.e8.
Erdem B., Aşıcıoğlu O., Seyhan N.A., Peker N., Ülker V., Akbayır Ö. Can concurrent high-risk endometrial carcinoma occur with atypical endometrial hyperplasia? Int. J. Surg. 2018; 53: 350–3.doi: 10.1016/j.ijsu.2018.04.019.
Iversen M.L., Dueholm M. Complex non atypical hyperplasia and the subsequent risk of carcinoma, atypia and hysterectomy during the following 9-14 years. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018; 222: 171–5.doi: 10.1016/j.ejogrb.2018.01.026.
International Classification of Diseases 10th Revision, World Health Organization; 2010. Available at: https://icd.who.int/browse10/2016/en#/N80-N98. Accessed: 01.06.2018.
Kadirogullari P., Atalay C.R., Ozdemir O., Sari E.M. Prevalence of co-existing endometrial carcinoma in patients with preoperative diagnosis of endometrial hyperplasia.J. Clin.Diagn. Res. 2015; 9 (10): QC10-4.
Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of Tumours of Female Reproductive Organs. Fourth Edition. 2014. Available at: http://apps.who.int/ bookorders/anglais/ detart1.jsp?codlan =1&codcol=70&codcch=
Lokuhetty D., White V. A., Watanabe R. Female Genital Tumours. 5th edn. Lyon: Internal Agency for Research on Cancer (IARC), 2020
Management of Endometrial Hyperplasia Green-top Guideline No. 67 RCOG/BSGE Joint Guideline | February 2016.
Оrbo A., Arnes M., Vereide A., Straume B. Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens.BJOG. 2016; 123 (9): 1512–9. doi: 10.1111/1471-0528.13763.
Owings RA, Quick CM. Endometrial intraepithelial neoplasia. Arch Pathol Lab Med. 2014;138:484-91.
